<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03694132</url>
  </required_header>
  <id_info>
    <org_study_id>C17-70</org_study_id>
    <nct_id>NCT03694132</nct_id>
  </id_info>
  <brief_title>Brain Excitability and Connectivity in Sensory-motor Pathways in ALS</brief_title>
  <acronym>SOM_ALS</acronym>
  <official_title>Evaluation and Characterization of Infraclinical Sensory Deficits in Amyotrophic Lateral Sclerosis by Brain Imaging and Electrophysiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to determine the origin of somatosensory alteration in patients with
      ALS and to evaluate its impact on brain activity by coupling different imaging modalities and
      indirect electrophysiology.

      The secondary objective is to evaluate whether the observed functional changes in MEG / EEG
      and functional MRI correlate with structural lesions revealed with diffusion MRI
      (anatomo-functional connectivity of the brain).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Somatosensory evoked potentials (SEPs) produced by ulnar nerve electrical stimulation will be
      collected with combined MEG and EGG.

      Functional MRI will be performed during electrical stimulation of ulnar nerve and during
      mechanical vibration of ADM tendon.

      Brain diffusion MRI will be performed. Anatomical MRI will be done for source location. Brain
      resting state activity will be recorded with MEG/EEG and fMRI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Anticipated">April 6, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients vs. health subjects</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activity</measure>
    <time_frame>1 hour</time_frame>
    <description>Brain parametric maps</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain connectivity</measure>
    <time_frame>15 min</time_frame>
    <description>diffusion brain MRI (tractography)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>functional MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a group of patients with ALS and a group of gender and age matched healthy subjects will have functional MRI acquisition conditioned by electrical and mechanical stimuli of ADM proprioceptors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>structural MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a group of patients with ALS and a group of gender and age matched healthy subjects will have diffusion MRI acquisition to evaluate their brain structures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EEG/MEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a group of patients with ALS and a group of gender and age matched healthy subjects will have functional MRI acquisition conditioned by electrical stimuli of ADM proprioceptors</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>functional MRI</intervention_name>
    <description>conditioning brain activity with peripheral stimulations</description>
    <arm_group_label>functional MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>structural MRI</intervention_name>
    <description>diffusion MRI and tractography for evaluating the brain structures</description>
    <arm_group_label>structural MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG/MEG</intervention_name>
    <description>conditioning brain activity with peripheral stimulations</description>
    <arm_group_label>EEG/MEG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ALS, MRC score ≥ 4 at least in one hand

          -  Controls: no history of neurological disorders, right-handed

        Exclusion Criteria:

          -  contraindication to MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>controls will be gender and age-matched to ALS</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veronique Marchand-Pauvert, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veronique Marchand-Pauvert, PhD</last_name>
    <phone>142161120</phone>
    <phone_ext>33</phone_ext>
    <email>veronique.marchand-pauvert@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
    <phone>142162471</phone>
    <phone_ext>33</phone_ext>
    <email>pierre-francois.pradat@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Pitie-Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronique Marchand-Pauvert, PhD</last_name>
      <phone>142161120</phone>
      <phone_ext>33</phone_ext>
      <email>veronique.marchand-pauvert@inserm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Sangari S, Giron A, Marrelec G, Pradat PF, Marchand-Pauvert V. Abnormal cortical brain integration of somatosensory afferents in ALS. Clin Neurophysiol. 2018 Apr;129(4):874-884. doi: 10.1016/j.clinph.2017.12.008. Epub 2017 Dec 24.</citation>
    <PMID>29317192</PMID>
  </results_reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2018</study_first_posted>
  <last_update_submitted>December 20, 2018</last_update_submitted>
  <last_update_submitted_qc>December 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain excitability</keyword>
  <keyword>Brain connectivity</keyword>
  <keyword>Motor cortex</keyword>
  <keyword>Somatosensory cortex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

